Cardiology Portfolio
Evidence-based statins, antiplatelets, ARNI, ARB's and beta-blockers manufactured to WHO, cGMP standards with reliable options for lipid control and cardiac risk management.
Diabetology Solutions
A focused range for Type 2 diabetes care, including DPP-4 and SGLT2–based formulations—consistent quality to support better glycemic outcomes.